UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sound absorption by suspensions of nonspherical particles: measurements compared with predictions using various particle sizing techniques

The Journal of the Acoustical Society of America, 2003-10, Vol.114 (4 Pt 1), p.1841-1850

2003

Volltextzugriff (PDF)

Determination of the viscous and thermal characteristic lengths of plastic foams by ultrasonic measurements in helium and air

Journal of applied physics, 1996-08, Vol.80 (4), p.2009-2012

1996

Volltextzugriff (PDF)

Measurement of viscous sound absorption at 50–150 kHz in a model turbid environment

The Journal of the Acoustical Society of America, 1998-10, Vol.104 (4), p.2114-2120

1998

Volltextzugriff (PDF)

Turbidity in future high-frequency sonar performance models

The Journal of the Acoustical Society of America, 1998-05, Vol.103 (5_Supplement), p.2900-2900

1998

Volltextzugriff (PDF)

Measurement of tortuosity of anisotropic acoustic materials

Journal of applied physics, 1995-10, Vol.78 (8), p.4929-4932

1995

Volltextzugriff (PDF)

Measurement at low ultrasonic frequencies of absorption due to suspended particulate matter

The Journal of the Acoustical Society of America, 1998-05, Vol.103 (5_Supplement), p.2900-2900

1998

Volltextzugriff (PDF)

Sustainability of the gifted education program within the Calgary Board of Education

Brown, James Niven

2004

Volltextzugriff (PDF)

A scoping review of full-spectrum knowledge translation theories, models, and frameworks

Implementation science : IS, 2020-02, Vol.15 (1), p.11-11, Article 11

2020

Volltextzugriff (PDF)

Visual feature binding in younger and older adults: encoding and suffix interference effects

Memory (Hove), 2017-02, Vol.25 (2), p.261-275

2017

Volltextzugriff (PDF)

996: MAXIMIZING THE GOLDEN HOUR IN CRITICALLY ILL PATIENTS: ASSESSMENT GAPS AT THE TIME OF ADMISSION

Critical care medicine, 2023-01, Vol.51 (1), p.491-491

2023

Volltextzugriff (PDF)

Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial

The lancet oncology, 2023-10, Vol.24 (10), p.1094-1108

2023

Volltextzugriff (PDF)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era

Thorax, 2021-03, Vol.76 (3), p.220-227

2021

Volltextzugriff (PDF)

Response to letter to the editor

Implementation science : IS, 2020-07, Vol.15 (1), p.1-52, Article 52

2020

Volltextzugriff (PDF)

Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells

Biochimica et biophysica acta. Bioenergetics, 2018-09, Vol.1859 (9), p.975-983

2018

Volltextzugriff (PDF)

1090: IMPLEMENTATION OF EDUCATIONAL TELEROUNDING PROGRAM DURING THE CONFLICT IN UKRAINE: A PILOT STUDY

Critical care medicine, 2024-01, Vol.52 (1), p.S517-S517

2024

Volltextzugriff (PDF)

855: EVALUATION OF CERTAIN UKRAINE ASYNCHRONOUS BEST PRACTICES IN SOCIAL MEDIA ENGAGEMENT

Critical care medicine, 2023-01, Vol.51 (1), p.419-419

2023

Volltextzugriff (PDF)

Association of baseline characteristics with adverse events (AEs) in the PROpel trial of olaparib (ola) plus abiraterone (abi) as first-line (1L) treatment for metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e17030-e17030

2024

Volltextzugriff (PDF)

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

Journal of allergy and clinical immunology, 2013-12, Vol.132 (6), p.1295-1302.e3

2013

Volltextzugriff (PDF)

Implementation of a Multimodal Knowledge-Exchange Platform to Provide Trauma Critical Care Education During the Ongoing Conflict in Ukraine

JAMA network open, 2023-02, Vol.6 (2), p.e230050-e230050

2023

Volltextzugriff (PDF)

Efficacy of olaparib (O) plus abiraterone (A) versus placebo (P) plus A in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with single homologous recombination repair gene mutations (HRRm) in the PROpel trial

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.165-165

2024

Volltextzugriff (PDF)

Final overall survival (OS) in PROpel: Abiraterone (abi) and olaparib (ola) versus abiraterone and placebo (pbo) as first-line (1L) therapy for metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.LBA16-LBA16

2023

Volltextzugriff (PDF)

859: STOP-TRAUMA: STRUCTURED TEAM-BASED OPTIMAL CRITICAL CARE FOR TRAUMA VICTIMS

Critical care medicine, 2023-01, Vol.51 (1), p.422-422

2023

Volltextzugriff (PDF)

Genome-wide association study to identify genetic determinants of severe asthma

Thorax, 2012-09, Vol.67 (9), p.762-768

2012

Volltextzugriff (PDF)

PROpel: Phase III trial of olaparib (ola) and abiraterone (abi) versus placebo (pbo) and abi as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.11-11

2022

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(19)
Humans
(14)
Biological And Medical Sciences
(7)
Adult
(6)
Asthma
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Male
(6)
Aged
(5)
Clinical Trials
(5)
Middle Aged
(5)
Patients
(5)
Acoustics
(4)
Allergy
(4)
Female
(4)
General & Internal Medicine
(4)
Immunology
(4)
Medicine, General & Internal
(4)
Social Sciences
(4)
Young Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sound absorption by suspensions of nonspherical particles: measurements compared with predictions using various particle sizing techniques

Determination of the viscous and thermal characteristic lengths of plastic foams by ultrasonic measurements in helium and air

Measurement of viscous sound absorption at 50–150 kHz in a model turbid environment

Turbidity in future high-frequency sonar performance models

Measurement of tortuosity of anisotropic acoustic materials

Measurement at low ultrasonic frequencies of absorption due to suspended particulate matter

Sustainability of the gifted education program within the Calgary Board of Education

A scoping review of full-spectrum knowledge translation theories, models, and frameworks

Visual feature binding in younger and older adults: encoding and suffix interference effects

996: MAXIMIZING THE GOLDEN HOUR IN CRITICALLY ILL PATIENTS: ASSESSMENT GAPS AT THE TIME OF ADMISSION

Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era

Response to letter to the editor

Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells

1090: IMPLEMENTATION OF EDUCATIONAL TELEROUNDING PROGRAM DURING THE CONFLICT IN UKRAINE: A PILOT STUDY

855: EVALUATION OF CERTAIN UKRAINE ASYNCHRONOUS BEST PRACTICES IN SOCIAL MEDIA ENGAGEMENT

Association of baseline characteristics with adverse events (AEs) in the PROpel trial of olaparib (ola) plus abiraterone (abi) as first-line (1L) treatment for metastatic castration-resistant prostate cancer (mCRPC)

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

Implementation of a Multimodal Knowledge-Exchange Platform to Provide Trauma Critical Care Education During the Ongoing Conflict in Ukraine

Efficacy of olaparib (O) plus abiraterone (A) versus placebo (P) plus A in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with single homologous recombination repair gene mutations (HRRm) in the PROpel trial

MP11-16 PROSTATE-SPECIFIC ANTIGEN ANALYSES IN PROPEL: ABIRATERONE AND OLAPARIB VERSUS ABIRATERONE AND PLACEBO AS FIRST-LINE THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Final overall survival (OS) in PROpel: Abiraterone (abi) and olaparib (ola) versus abiraterone and placebo (pbo) as first-line (1L) therapy for metastatic castration-resistant prostate cancer (mCRPC)

859: STOP-TRAUMA: STRUCTURED TEAM-BASED OPTIMAL CRITICAL CARE FOR TRAUMA VICTIMS

Genome-wide association study to identify genetic determinants of severe asthma

PROpel: Phase III trial of olaparib (ola) and abiraterone (abi) versus placebo (pbo) and abi as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Suchergebnisse filtern